Post-marketing observational study on the efficacy and safety of Neuroguidewire and Guide Catheter NV2 for the treatment of AVM embolizatio

Not Applicable

Recruiting

• Conditions: cerebral arteriovenous malformations (brain AVM); brain AVM; Intracranial Arteriovenous Malformations, MeSH Unique ID: D002538

• Registration Number: JPRN-jRCT1052230050
• Lead Sponsor: Kugai Miyahito

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-06-24
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

1.Patients who have undergone endovascular treatment for cerebral arteriovenous malformations using CHIKAI guidewires or FUBUKI guiding catheters during the investigations period.
2.Patients who have given consent for the use of their medical information.

Exclusion Criteria

1.Patients treated with unapproved medical devices.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The rate of successful delivery of the micro catheter to the targeted locaton in the neurovasculature (Y/N).<br>Definition of successful delivery; The microcatheter tip should be located in an anatomically desirable location int the vessel to be treated.